Author

Ari Azhir

Observed names: A Azhir, Ari AZHIR, Ari Azhir Phd

Observed institutions: Houston Methodist, University of Kansas, University of California, San Francisco, University of Tehran, California Pacific Medical Center, Massachusetts General Hospital

OpenAlex ID: A5010385643

Randomized phase 2 trial of NP001, a novel immune regulator

2015 · Robert G. Miller, Gilbert Block, et al. · Neurology Neuroimmunology & Neuroinflammation · 99

Phase 2B randomized controlled trial of NP001 in amyotrophic lateral sclerosis: Pre‐specified and post hoc analyses

2022 · Robert G. Miller, Rongzhen Zhang, et al. · Muscle & Nerve · 35

Macrophage-Targeted Sodium Chlorite (NP001) Slows Progression of Amyotrophic Lateral Sclerosis (ALS) through Regulation of Microbial Translocation

2022 · Rongzhen Zhang, Paige M. Bracci, et al. · Biomedicines · 18

Measurement of Testosterone and Dehydroepiandrosterone 16α‐Hydroxylase Activities by a Tritium Exchange Method

1978 · Pierre KREMERS, Jean De GRAEVE, et al. · European Journal of Biochemistry · 16

Regulation of the Innate Immune System as a Therapeutic Approach to Supporting Respiratory Function in ALS

2023 · Michael S. McGrath, Rongzhen Zhang, et al. · Cells · 14

The Effectiveness of NP001 on the Long-Term Survival of Patients with Amyotrophic Lateral Sclerosis

2024 · Bruce D. Forrest, Namita A. Goyal, et al. · Biomedicines · 5

The Effectiveness of NP001 on Long Term Survival of Patients with Amyotrophic Lateral Sclerosis: The IKARIA Study

2024 · Bruce Darren Forrest, Namita A. Goyal, et al. · SSRN Electronic Journal · 4

Respiratory Function Improvement and Lifespan Extension Following Immunotherapy with NP001 Support the Concept That Amyotrophic Lateral Sclerosis (ALS) Is an Immuno-Neurologic Disease

2025 · Rongzhen Zhang, Ari Azhir, et al. · International Journal of Molecular Sciences · 3

Systemic Innate Immune System Restoration as a Therapeutic Approach for Neurodegenerative Disease: Effects of NP001 on Amyotrophic Lateral Sclerosis (ALS) Progression

2024 · Michael S. McGrath, Rongzhen Zhang, et al. · Biomedicines · 2

Quantitative Measures of Time to Loss of 15% Vital Capacity and Survival Extension in Slowly Progressive Amyotrophic Lateral Sclerosis (ALS) Patients Treated with the Immune Regulator NP001 Suggests an Immunopathogenic Subset of ALS

2025 · Namita A. Goyal, Jinsy A. Andrews, et al. · Biomedicines

[New method for the determination of liver testosterone and dehydroepiandrosterone 16-alpha-hydroxylase (proceedings)].

1977 · P Kremers, A Azhir, et al. · PubMed

Works count: 12

Citation count: 196

H-index: 5

I10-index: 5